The current study builds upon our previous findings and other reports on GV1001, proposing the hypothesis that GV1001 prevents the development (or reduces the severity) of Pg-induced periodontitis and periodontitis-associated systemic disorders, such as atherosclerosis and AD-like conditions in Apolipoprotein E (ApoE)-deficient mice. Here, APOE is linked to atherosclerosis.